Get started
Author

Marija McGeachie

Observed name: McGeachie, Marija
ORCID: 0000-0002-5554-0253
Observed ORCID: 0000-0002-5554-0253
OpenAlex ID: A5058511648
Understanding the Treatment Preferences of People Living with Schizophrenia in Australia; A Patient Value Mapping Study
2022 · Simon Fifer, Brittany Keen, et al. · Patient Preference and Adherence · 17
PDF
Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia
2022 · Stephen P. Mulligan, Stephen Opat, et al. · British Journal of Haematology · 12
Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia
2024 · Simon Fifer, Jenni Godsell, et al. · BMC Cancer · 11
Real-world experience of Australian and New Zealand patients with chronic lymphocytic leukemia and mantle cell lymphoma accessing ibrutinib through a Named Patient Program
2022 · Stephen P. Mulligan, Stephen Opat, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 8
Asia-Pacific practical consensus in the management of adverse events related to amivantamab-based therapies in non-small cell lung cancer
2026 · Ross A. Soo, Pablo Fernandez-Penas, et al. · Lung Cancer · 2
Australian data on the utilisation and duration on treatment of ibrutinib with a proton pump inhibitor in patients with relapsed or refractory chronic lymphocytic leukaemia
2023 · Ross Salvaris, Stephen Mulligan, et al. · Internal Medicine Journal · 2
PDF
Works count: 10
Citation count: 52
H-index: 4
I10-index: 3
Year
Topic
Type